Trends and projections of the syphilis burden in China: an analysis of GBD 2021 data and global comparison
Abstract
ObjectivesChina accounts for a significant proportion of the global burden of syphilis, yet detailed comparisons of long-term epidemiological trends between China and the global population at present remain lacking.MethodsData on syphilis for China and the global population from 1990 to 2021 were extracted from the Global Burden of Disease (GBD) Study 2021. Joinpoint regression analysis was employed to identify the temporal trend. Age and sex distributions were examined, and mortality and DALY rate attributable to unsafe sex were analyzed. The future syphilis burden from 2022 to 2041 was estimated using the Nordpred model, and alternative model-based scenario analysis was conducted using complementary ARIMA and Holt-Winters models.ResultsBetween 1990 and 2021, the number of incident cases and prevalent cases of syphilis increased by 3.64% and 12.87% in China, respectively, whereas deaths and DALYs declined by 55.75% and 55.65%, respectively. China’s age-standardized incidence rates (ASIR), age-standardized prevalence rates (ASPR), age-standardized mortality rates (ASMR), and age-standardized disability-adjusted life-year rates (ASDR) remained substantially below global levels over the 32-year period. Joinpoint analysis revealed that China’s ASMR and ASDR increased sharply during 2019–2021, with APCs of 20.75% and 20.36%, far exceeding the corresponding global values (4.43% and 4.54%). Across China and globally, ASMR and ASDR reached their highest levels among children under five, while unsafe sex-linked syphilis mortality was greatest among those aged 80 and above. Nordpred projects continued decline in China’s ASIR, ASPR, and ASDR for syphilis through 2041. In contrast, both the ARIMA and Holt-Winters models forecast upward trends in ASIR, ASPR, and ASDR.ConclusionSyphilis-related ASMR and ASDR increased during 2019–2021, a period coinciding with the COVID-19 pandemic and the final evaluation year of the National Syphilis Prevention and Control Plan. This observation warrants further investigation into the potential contributions of healthcare disruptions, surveillance artifacts, and changes in reporting practices. Strengthening prenatal syphilis screening and timely, evidence-based treatment is essential to prevent congenital syphilis; concurrently, enhancing clinicians’ diagnostic proficiency for complications associated with late-stage syphilis is critically important.
Related
- The Changing Global Epidemiology of Early-Onset Colorectal Cancer: Incidence Trends, Modifiable Risk Factors, and Future Burden Projections
- Global burden, trends, and projections of five major upper gastrointestinal diseases, 1990–2046: an analysis of GBD 2021
- Burden, trends, and projections of prostate cancer: global cancer statistics (GLOBOCAN) estimates for 2024 and 2022
- Trends and future projections of Parkinson’s disease burden in China: findings from the Global Burden of Disease Study 2023
- Trends, decomposition, and projections of gout burden among middle-aged adults in China : GBD 2023
BibTeX
@article{li2026trends,
title = {{Trends and projections of the syphilis burden in China: an analysis of GBD 2021 data and global comparison}},
author = {Wei Li and Wei Wei and Wei-Feng Shen},
journal = {Frontiers in Public Health},
year = {2026},
month = nov,
doi = {10.3389/fpubh.2026.1960182},
url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1960182},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Trends and projections of the syphilis burden in China: an analysis of GBD 2021 data and global comparison
AU - Wei Li
AU - Wei Wei
AU - Wei-Feng Shen
PY - 2026
DA - 2026/11/06
JO - Frontiers in Public Health
DO - 10.3389/fpubh.2026.1960182
UR - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1960182
AB - ObjectivesChina accounts for a significant proportion of the global burden of syphilis, yet detailed comparisons of long-term epidemiological trends between China and the global population at present remain lacking.MethodsData on syphilis for China and the global population from 1990 to 2021 were extracted from the Global Burden of Disease (GBD) Study 2021. Joinpoint regression analysis was employed to identify the temporal trend. Age and sex distributions were examined, and mortality and DALY rate attributable to unsafe sex were analyzed. The future syphilis burden from 2022 to 2041 was estimated using the Nordpred model, and alternative model-based scenario analysis was conducted using complementary ARIMA and Holt-Winters models.ResultsBetween 1990 and 2021, the number of incident cases and prevalent cases of syphilis increased by 3.64% and 12.87% in China, respectively, whereas deaths and DALYs declined by 55.75% and 55.65%, respectively. China’s age-standardized incidence rates (ASIR), age-standardized prevalence rates (ASPR), age-standardized mortality rates (ASMR), and age-standardized disability-adjusted life-year rates (ASDR) remained substantially below global levels over the 32-year period. Joinpoint analysis revealed that China’s ASMR and ASDR increased sharply during 2019–2021, with APCs of 20.75% and 20.36%, far exceeding the corresponding global values (4.43% and 4.54%). Across China and globally, ASMR and ASDR reached their highest levels among children under five, while unsafe sex-linked syphilis mortality was greatest among those aged 80 and above. Nordpred projects continued decline in China’s ASIR, ASPR, and ASDR for syphilis through 2041. In contrast, both the ARIMA and Holt-Winters models forecast upward trends in ASIR, ASPR, and ASDR.ConclusionSyphilis-related ASMR and ASDR increased during 2019–2021, a period coinciding with the COVID-19 pandemic and the final evaluation year of the National Syphilis Prevention and Control Plan. This observation warrants further investigation into the potential contributions of healthcare disruptions, surveillance artifacts, and changes in reporting practices. Strengthening prenatal syphilis screening and timely, evidence-based treatment is essential to prevent congenital syphilis; concurrently, enhancing clinicians’ diagnostic proficiency for complications associated with late-stage syphilis is critically important.
SN - 2296-2565
ER -